Differences in RNA expression in response to MC and DMC stereoisomeric interstrandcrosslinks (Student: Christina Gonzalez)

MC 和 DMC 立体异构链间交联反应中 RNA 表达的差异（学生：Christina Gonzalez）

• 批准号: 10378888
• 负责人: Elise Champeil
• 金额: $ 2.27万
• 依托单位: JOHN JAY COLLEGE OF CRIMINAL JUSTICE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-07-01 至 2023-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10378888
• 关键词: Antineoplastic Agents; Apoptotic; Attention; Biochemical; Cell Cycle Arrest; Cell Death; Cells; DNA Adducts; DNA Interstrand Crosslinking; DNA Structure; Environment; Exposure to; Fostering; Genetic Transcription; Goals; Health; Human; Laboratory Research; Malignant Neoplasms; Malignant neoplasm of anus; Malignant neoplasm of lung; Manuscripts; Measures; Medical Research; Mitomycin C; Mitomycins; Modeling; Molecular; Mutate; Oligonucleotides; Outcome; Parents; Pathway interactions; Pharmaceutical Preparations; Publishing; RNA; Research; Research Proposals; Scientist; Signal Transduction; Structure; Students; TP53 gene; Training; Training Activity; Work; base; career; chemotherapeutic agent; crosslink; cytotoxic; genetic makeup; improved; malignant stomach neoplasm; parent project; personalized medicine; programs; response; skills; symposium; transcription factor; tumor

Summary: The overarching goal of the parent proposal for this “research supplement to promote diversity in health-related research” is to investigate the relationship between the structure of stereoisomeric DNA Interstrand Crosslinks (ICLs) formed by Mitomycin C and Decarbamoylmitomycin C and the molecular mechanisms of these drugs. Mitomycin C (MC) is an anticancer drug currently used to treat stomach, anal and lung cancers. The stereochemical configuration at C1’’ of MC major ICL is R (α-ICL). In contrast, Decarbamoylmitomycin C (DMC), a derivative of MC lacking the O10 carbamoyl group, generates the S stereoisomeric ICL (β-ICL). The scientific premise of the proposed research is that ICLs constitute the molecular basis for the cytotoxic effects of mitomycins. The central hypothesis is that differences in the local DNA structures of the α and β- ICLs are responsible for the distinct biochemical responses triggered by MC and DMC. In particular, contrary to MC, the DNA-adducts generated by DMC treatment (-ICL) rapidly activate a p53-independent cell death pathway. Thus, the study MC-DMC provides an ideal model for identifying structural features determining the cell signaling outcome in the presence or the absence of a functioning p53 pathway. Since p53 tumor suppressor is frequently mutated in human cancers, the need to identify drugs and pathways that induce cell death or cell cycle arrest independently of p53 deserves substantial attention. Within the scope of the parent project, this supplement to promote diversity in health-related research will be used to train the candidate, Christina Gonzalez to: 1) Synthesize oligonucleotides containing α/β ICLs; 2) Transfect cells with MC/DMC and the ICLs; 3) extract RNA; 4) measure RNA expression levels and identify specific pathways relevant to exposure. Christina’s long-term goal is to become a medical research scientist. The training and activities proposed will improve Christina’s chances to access MD-PHD programs by fostering crucial technical and professional skills. As Christina gains new exposure to the research environment, she will become more comfortable interacting with other scientists and sharing her work. She will be fully prepared to join a research laboratory. To further enhance Christina’s competitiveness, she will present her research findings at conferences and publish at least one manuscript. She will also receive career advisement from Dr Edgardo Sanabria- Valentin, the PRISM Associate Program Director and Pre-Health Career Advisor. He will assist Christina in considering long-term career goals and the skills needed to achieve them.

简介: